Archon Biosciences
Pre-clinicalA revolutionary class of computationally designed biologics engineered to unlock challenging pathways and better treat disease
Founded
2024
Focus
AntibodiesBiologics
About
A revolutionary class of computationally designed biologics engineered to unlock challenging pathways and better treat disease
Funding History
2Total raised: $30M
Series A$25MARCH Venture PartnersMay 15, 2022
Seed$5MUndisclosedSep 15, 2020
Company Info
TypePrivate
Founded2024
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile